Who Benefits from Cardiac Resynchronization Therapy
Principal Investigator Name:
Charles Henrikson, M.D.
Study Coordinator Name:
Elizabeth Robinson, R.N.
Contact Phone: Study Coordinator
(410) 502 - 0517
Contact E-mail: Study Coordinator
erobin26@jhmi.edu
Study Short Title:
WBC
Study Long Title:
Who Benefits from Cardiac Resynchronization Therapy
IRB Number:
WIRB 20061053
Funding Source:
St. Jude Medical
Summary of Trial:
To determine if an algorithm can be developed based on pre-implant clinical variables to predict responses to CRT therapy. Any patient who receives an FDA approved SJM CRT-D is eligible for enrollment.
Inclusions:
New York Heart Association Class III or IV
QRS > 130 msec
Ejection Fraction < 35% within last 6 months
Clinical indication for CRT-D therapy
Exclusions:
Unstable angina
Patients with an ICD or pacemaker
Patients that require revascularization
Clinical Trial Site:
Johns Hopkins University 600 N. Wolfe Street, Carnegie 586 Baltimore, MD 21287
